HU225990B1 - Use of beta-adrenergic agonists for the preparation of medicaments for treating endometriosis, infertility or improving fertility - Google Patents

Use of beta-adrenergic agonists for the preparation of medicaments for treating endometriosis, infertility or improving fertility Download PDF

Info

Publication number
HU225990B1
HU225990B1 HU0203050A HUP0203050A HU225990B1 HU 225990 B1 HU225990 B1 HU 225990B1 HU 0203050 A HU0203050 A HU 0203050A HU P0203050 A HUP0203050 A HU P0203050A HU 225990 B1 HU225990 B1 HU 225990B1
Authority
HU
Hungary
Prior art keywords
use according
terbutaline
adrenergic agonist
endometriosis
uterine
Prior art date
Application number
HU0203050A
Other languages
English (en)
Hungarian (hu)
Inventor
William J Bologna
Dominique De Ziegler
Howard L Levine
Original Assignee
Columbia Lab Bermuda Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Columbia Lab Bermuda Ltd filed Critical Columbia Lab Bermuda Ltd
Publication of HUP0203050A2 publication Critical patent/HUP0203050A2/hu
Publication of HUP0203050A3 publication Critical patent/HUP0203050A3/hu
Publication of HU225990B1 publication Critical patent/HU225990B1/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Emergency Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
HU0203050A 1999-10-05 2000-10-04 Use of beta-adrenergic agonists for the preparation of medicaments for treating endometriosis, infertility or improving fertility HU225990B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15775499P 1999-10-05 1999-10-05
US66838400A 2000-09-25 2000-09-25
PCT/EP2000/009708 WO2001024788A2 (en) 1999-10-05 2000-10-04 Treating endometriosis or infertility, or improving fertility

Publications (3)

Publication Number Publication Date
HUP0203050A2 HUP0203050A2 (hu) 2003-02-28
HUP0203050A3 HUP0203050A3 (en) 2006-02-28
HU225990B1 true HU225990B1 (en) 2008-02-28

Family

ID=26854456

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0203050A HU225990B1 (en) 1999-10-05 2000-10-04 Use of beta-adrenergic agonists for the preparation of medicaments for treating endometriosis, infertility or improving fertility

Country Status (28)

Country Link
EP (1) EP1220667B1 (cg-RX-API-DMAC7.html)
JP (2) JP2003510354A (cg-RX-API-DMAC7.html)
KR (1) KR100738724B1 (cg-RX-API-DMAC7.html)
CN (1) CN1218694C (cg-RX-API-DMAC7.html)
AR (1) AR028487A1 (cg-RX-API-DMAC7.html)
AT (1) ATE271860T1 (cg-RX-API-DMAC7.html)
AU (1) AU780736B2 (cg-RX-API-DMAC7.html)
BR (1) BR0014548A (cg-RX-API-DMAC7.html)
CA (1) CA2385974C (cg-RX-API-DMAC7.html)
CO (1) CO5251423A1 (cg-RX-API-DMAC7.html)
DE (1) DE60012554T2 (cg-RX-API-DMAC7.html)
DK (1) DK1220667T3 (cg-RX-API-DMAC7.html)
ES (1) ES2223581T3 (cg-RX-API-DMAC7.html)
GE (1) GEP20043313B (cg-RX-API-DMAC7.html)
HK (1) HK1044120B (cg-RX-API-DMAC7.html)
HU (1) HU225990B1 (cg-RX-API-DMAC7.html)
IL (2) IL148784A0 (cg-RX-API-DMAC7.html)
MA (1) MA25501A1 (cg-RX-API-DMAC7.html)
MX (1) MXPA02003453A (cg-RX-API-DMAC7.html)
MY (1) MY129518A (cg-RX-API-DMAC7.html)
NO (1) NO329663B1 (cg-RX-API-DMAC7.html)
NZ (1) NZ518429A (cg-RX-API-DMAC7.html)
PE (1) PE20010742A1 (cg-RX-API-DMAC7.html)
PT (1) PT1220667E (cg-RX-API-DMAC7.html)
TR (1) TR200200899T2 (cg-RX-API-DMAC7.html)
TW (1) TWI280877B (cg-RX-API-DMAC7.html)
UA (1) UA74168C2 (cg-RX-API-DMAC7.html)
WO (1) WO2001024788A2 (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8425892B2 (en) 2001-10-29 2013-04-23 Columbia Laboratories, Inc. Extended, controlled-release pharmaceutical compositions using charged polymers
CN101327326A (zh) * 2001-10-29 2008-12-24 哥伦比亚实验室(百慕大群岛)有限公司 阴道给药治疗骨盆痛和不孕症的抗节律障碍剂
ES2237298B1 (es) 2003-07-16 2006-11-01 Italfarmaco, S.A. Formulaciones mucoadhesivas semisolidas.
EP1872775A1 (en) 2006-06-29 2008-01-02 Polichem S.A. Use of a hydrophilic matrix comprising a polyacrylic acid derivative, a cellulose ether and a disintegrant for the manufacture of a medicament for treating female genital disorders
ES2344673B1 (es) 2008-08-07 2011-05-03 Italfarmaco, S.A. Uso de estriol en la preparacion de una formulacion farmaceutica parael tratamiento de atrofia vaginal en mujeres con riesgo de potologiatumoral.
ES2344675B1 (es) 2008-12-19 2011-04-28 Italfarmaco, S.A. Uso de estriol en la preparacion de una formulacion farrmaceutica para el tratamiento de atrofia vaginal en mujeres con riesgo de patologiacardiovascular.
MX2012010327A (es) * 2010-03-22 2012-11-16 Repros Therapeutics Inc Composiciones y metodos para la administracion no toxica de antiprogestinas.
KR101010031B1 (ko) * 2010-12-08 2011-01-21 류상범 흡수식 냉온수기용 엘리미네이터
CA2872644A1 (en) 2012-05-31 2013-12-05 Allergan Pharmaceuticals International Limited Formulations and methods for vaginal delivery of antiprogestins
US9545411B2 (en) 2012-11-02 2017-01-17 Repros Therapeutics Inc. Methods and compositions for treating progesterone-dependent conditions
CN116172995A (zh) * 2023-01-17 2023-05-30 浙江大学医学院附属妇产科医院 一种沙丁胺醇在制备治疗子宫内膜异位症的药物中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4241087A (en) * 1979-04-02 1980-12-23 William H. Rorer, Inc. Dysmenorrhea treatment
NZ232801A (en) * 1989-03-07 1992-01-29 Adeza Biomedical Corp Diagnostic test for endometriosis
JP2602456B2 (ja) * 1990-04-12 1997-04-23 雪印乳業株式会社 子宮内膜症治療剤
IT1251114B (it) * 1991-07-26 1995-05-04 Farcon Ag Forme farmaceutiche antivirali per applicazione vaginale
DE69819748T2 (de) * 1997-09-12 2004-09-30 Columbia Laboratories (Bermuda) Ltd. Arzneimittel zur behandlung von dysmenorrhöe und verfrühten wehen

Also Published As

Publication number Publication date
KR100738724B1 (ko) 2007-07-12
IL148784A0 (en) 2002-09-12
EP1220667B1 (en) 2004-07-28
CA2385974C (en) 2010-01-26
NO20021591D0 (no) 2002-04-04
CN1377264A (zh) 2002-10-30
HK1044120A1 (en) 2002-10-11
TR200200899T2 (tr) 2002-07-22
UA74168C2 (uk) 2005-11-15
MXPA02003453A (es) 2002-08-20
MY129518A (en) 2007-04-30
NZ518429A (en) 2004-02-27
WO2001024788A2 (en) 2001-04-12
NO20021591L (no) 2002-05-28
KR20020062285A (ko) 2002-07-25
CO5251423A1 (es) 2003-02-28
HUP0203050A3 (en) 2006-02-28
MA25501A1 (fr) 2002-07-01
AR028487A1 (es) 2003-05-14
ES2223581T3 (es) 2005-03-01
WO2001024788A3 (en) 2001-12-06
DE60012554D1 (de) 2004-09-02
HUP0203050A2 (hu) 2003-02-28
IL148784A (en) 2006-12-31
JP2010018639A (ja) 2010-01-28
DK1220667T3 (da) 2004-12-06
NO329663B1 (no) 2010-11-29
AU780736B2 (en) 2005-04-14
AU7525000A (en) 2001-05-10
CA2385974A1 (en) 2001-04-12
PE20010742A1 (es) 2001-07-19
CN1218694C (zh) 2005-09-14
EP1220667A2 (en) 2002-07-10
DE60012554T2 (de) 2005-11-24
GEP20043313B (en) 2004-03-10
PT1220667E (pt) 2004-11-30
HK1044120B (en) 2004-12-17
ATE271860T1 (de) 2004-08-15
JP2003510354A (ja) 2003-03-18
TWI280877B (en) 2007-05-11
BR0014548A (pt) 2002-06-04

Similar Documents

Publication Publication Date Title
KR100575386B1 (ko) 월경통 및 조숙분만진통의 예방 또는 치료용 약제학적 조성물
JP2010018639A (ja) 子宮内膜炎または不妊症の処置および妊孕性の改善
TW201204368A (en) Very low-dosed solid oral dosage forms for HRT
IL161513A (en) Pharmaceutical vaginal composition comprising lidocaine and a bioadhesive carrier, and its use in the manufacture of a medicament for the treatment of uterine dysrhythmia
WO2002089818A1 (en) Use of sucralfate for the treatment of cervical erosion
EP2219447B1 (en) S-alkylisothiouronium derivatives for treating uterine hypercontractility disorders
RU2310474C2 (ru) Способ лечения эндометриоза или бесплодия или улучшение способности к воспроизведению потомства и фармацевтическая композиция для его осуществления
Krishna et al. A review on vaginal drug delivery systems
US12011423B2 (en) S-alkylisothiouronium derivatives for treating uterine hypercontractility disorders
JP5204374B2 (ja) 荷電ポリマーを含有する長時間制御放出性の薬学的組成物
WO2025037299A1 (en) Method for treating endometriosis
EP1356806A1 (en) A pharmaceutical composition for treating dysmenorrhea and premature labor
HK1055896A (en) A pharmaceutical composition for treating dysmenorrhea and premature labor
HK1025055B (en) A pharmaceutical composition for treating dysmenorrhea and premature labor